&nbsp;

Dec 2024

Drug

lenalidomide

Other Name(s): Revlimid®

Quick Link(s):

Mar 2024

Drug

lomustine

Other Name(s): CeeNU®

Quick Link(s):

Aug 2024

Drug

temsirolimus

Other Name(s): Torisel ®

Quick Link(s):

Jun 2024

Drug

lanreotide

Other Name(s): Somatuline® Autogel®

Quick Link(s):

Jun 2024

Regimen

TEMS

Cancer Type:

Genitourinary,

Renal cell / Kidney

Intent: Palliative

Funding:

New Drug Funding Program

Temsirolimus - Metastatic Renal Cell Carcinoma

Drugs Used:

temsirolimus

Quick Link(s):

Regimen Monograph

Jun 2024

Regimen

LOMU

Cancer Type:

Central Nervous System

Intent: Palliative

Funding:

ODB - General Benefit

lomustine

Drugs Used:

lomustine

Quick Link(s):

Regimen Monograph

Aug 2024

Regimen

TRAS

Cancer Type:

Breast

Intent: Palliative

Funding:

New Drug Funding Program

Trastuzumab (Biosimilar) in combination with Chemotherapy - Metastatic Breast Cancer

New Drug Funding Program

Trastuzumab (Biosimilar) - Second Line - Metastatic Breast Cancer

Drugs Used:

trastuzumab

Quick Link(s):

Regimen Monograph

May 2024

Regimen

LANR

Cancer Type:

Gastrointestinal,

Neuroendocrine (GI),

Lung,

Neuroendocrine (Lung)

Intent: Palliative

Funding:

ODB - General Benefit

lanreotide

Drugs Used:

lanreotide

Quick Link(s):

Regimen Monograph

May 2024

Regimen

TMZL

Cancer Type:

Gastrointestinal,

Neuroendocrine (GI),

Lung,

Neuroendocrine (Lung)

Intent: Palliative

Funding:

ODB - General Benefit

temozolomide

Drugs Used:

temozolomide

Quick Link(s):

Regimen Monograph

Jun 2024

Drug

trifluridine / tipiracil

Other Name(s): Lonsurf®

Quick Link(s):

Nov 2024

Regimen

LOMU+BEVA

Cancer Type:

Central Nervous System

Intent: Palliative

Funding:

ODB - General Benefit

lomustine

New Drug Funding Program

Bevacizumab (Biosimilar) - In Combination with Lomustine for Recurrent Glioblastoma

Drugs Used:

lomustine,

bevacizumab